1. Home
  2. PGEN vs RYAM Comparison

PGEN vs RYAM Comparison

Compare PGEN & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • RYAM
  • Stock Information
  • Founded
  • PGEN 1998
  • RYAM 1926
  • Country
  • PGEN United States
  • RYAM United States
  • Employees
  • PGEN N/A
  • RYAM N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • RYAM Paper
  • Sector
  • PGEN Health Care
  • RYAM Basic Materials
  • Exchange
  • PGEN Nasdaq
  • RYAM Nasdaq
  • Market Cap
  • PGEN 493.0M
  • RYAM 477.7M
  • IPO Year
  • PGEN N/A
  • RYAM N/A
  • Fundamental
  • Price
  • PGEN $4.39
  • RYAM $7.33
  • Analyst Decision
  • PGEN Buy
  • RYAM Buy
  • Analyst Count
  • PGEN 5
  • RYAM 1
  • Target Price
  • PGEN $7.50
  • RYAM $6.00
  • AVG Volume (30 Days)
  • PGEN 5.2M
  • RYAM 620.5K
  • Earning Date
  • PGEN 11-13-2025
  • RYAM 11-04-2025
  • Dividend Yield
  • PGEN N/A
  • RYAM N/A
  • EPS Growth
  • PGEN N/A
  • RYAM N/A
  • EPS
  • PGEN N/A
  • RYAM N/A
  • Revenue
  • PGEN $4,340,000.00
  • RYAM $1,519,622,000.00
  • Revenue This Year
  • PGEN $249.10
  • RYAM N/A
  • Revenue Next Year
  • PGEN $710.03
  • RYAM $4.65
  • P/E Ratio
  • PGEN N/A
  • RYAM N/A
  • Revenue Growth
  • PGEN N/A
  • RYAM N/A
  • 52 Week Low
  • PGEN $0.65
  • RYAM $3.35
  • 52 Week High
  • PGEN $5.23
  • RYAM $10.28
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 67.29
  • RYAM 58.71
  • Support Level
  • PGEN $3.85
  • RYAM $7.14
  • Resistance Level
  • PGEN $4.24
  • RYAM $7.60
  • Average True Range (ATR)
  • PGEN 0.29
  • RYAM 0.32
  • MACD
  • PGEN 0.10
  • RYAM -0.08
  • Stochastic Oscillator
  • PGEN 92.79
  • RYAM 50.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: